Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)
Fluticasone Propionate Aerosol, Metered
Product Images NDC 68788-8762
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 68788-8762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)
This is not a readable text.*
Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)
This text provides information on the change from baseline in forced expiratory volume (FEV) for different doses of fluticasone propionate HFA compared to a placebo over a 12-week period. The doses of fluticasone propionate HFA mentioned are 83 mcg twice daily, 220 mcg twice daily, and 440 mcg twice daily.*
Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)
This text mentions the percentage of subjects at various dose levels of Fluticasone Propionate HFA (440 mcg twice daily and 880 mcg twice daily) and the percentage of subjects with an increase in dose. The data suggests a reduction in dose by 100% for some subjects.*
Figure A (Fluticasonepropionatehfa Spl Graphic 05)
This product seems to be a metal canister with a dark orange plastic actuator and mouthpiece, topped with a peach cap. The dark orange color scheme adds a stylish touch to the design.*
Figure B (Fluticasonepropionatehfa Spl Graphic 06)
Figure C (Fluticasonepropionatehfa Spl Graphic 07)
Figure D (Fluticasonepropionatehfa Spl Graphic 08)
Figure E (Fluticasonepropionatehfa Spl Graphic 09)
This may be a description related to a smoking device or accessory. The item seems to have a mouthpiece with the capability of being placed in a downward position. The color mentioned is dark orange.*
Figure F (Fluticasonepropionatehfa Spl Graphic 10)
This text describes the action of exhaling or breathing out as much air as possible. It is a simple and clear instruction related to breathing exercises or techniques.*
Figure G (Fluticasonepropionatehfa Spl Graphic 11)
Figure H (Fluticasonepropionatehfa Spl Graphic 12)
Figure I (Fluticasonepropionatehfa Spl Graphic 13)
Figure J (Fluticasonepropionatehfa Spl Graphic 14)
Fluticasone Propionate Hfa Inh Aerosol 44mcg (Fluticasonepropionatehfa Spl Graphic 15)
This text contains information about a medication called Fluticasone Propionate HFA Inhaler Aerosol 44mcg, which is a generic version of Flovent HFA. Each actuation of the inhaler delivers 50mcg of fluticasone propionate from the valve and 44mcg from the actuator. The medication is manufactured by Prasco Laboratories. The text also includes storage instructions, directions for use, a caution regarding federal law on drug transfer, and information in both English and Spanish. The text lacks specific details on indications or side effects of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
